Faeth Therapeutics raises $47 million to advance clinical trials and help fight cancer

The precise control of nutrients to starve cancer is supported by research from academic founders including Lev Cantley, Scott LoweSiddhartha Mukherjee, Gregory Hannonand Karen Vousden SAN FRANCISCO, June 30, 2022 /PRNewswire/ — Faeth Therapeuticsa cancer metabolism company, today announced the closure of a $47 million Series A round of private funding rounds led by S2G …

Faeth Therapeutics raises $47 million to advance clinical trials and help fight cancer Read More »